Diagnamed Holdings Corp. (CSE:DMED)
0.0600
-0.0050 (-7.69%)
May 21, 2026, 3:49 PM EST
Diagnamed Holdings Company Description
Diagnamed Holdings Corp. engages in developing a platform of software-based prescription digital therapeutic products for detecting brain age and tremors for neurological disorders. The company is headquartered in Vancouver, Canada.
Diagnamed Holdings Corp.
| Country | Canada |
| Industry | Health Information Services |
| Sector | Healthcare |
| CEO | John Karagiannidis |
Contact Details
Address: 82 Richmond Street East Toronto, ON ON Canada | |
| Phone | 416 800 2684 |
Stock Details
| Ticker Symbol | DMED |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| ISIN Number | CA25245D1033 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| John Karagiannidis | President, Chief Executive Officer and Director |
| Andre Turmel | Independent Executive Chairman |
| Edward Low | Interim Chief Financial Officer |
| Andrew Newbury CPA | Corporate Secretary |